合計 50 件の最近のインサイダー取引記録が記録されています Harmony Biosciences Holdings, Inc. (HRMY), 内訳は 21 件の買い および 26 件の売り. インサイダー買い総額は $10.32M インサイダー売り総額は $5.43M.
最近活動のある主要インサイダーには Ignelzi Troy A., Anastasiou Peter, Kapadia Sandip. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — HRMY
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-04-02 |
Ignelzi Troy A. |
Officer |
不明 |
- |
- |
- |
- |
| 2026-04-02 |
Ignelzi Troy A. |
Director |
RSU 付与（制限付株式） |
17,710 |
$27.74 |
$491.28K |
17,710 |
| 2026-04-02 |
Anastasiou Peter |
Chief Operating Officer |
RSU 付与（制限付株式） |
212,241 |
$27.74 |
$5.89M |
212,241 |
| 2026-01-26 |
Kapadia Sandip |
Chief Financial Officer |
情報に基づく売り |
3,746 |
$37.15 |
$139.17K |
24,521 |
| 2026-01-25 |
Dayno Jeffrey M. |
President, CEO |
RSU 源泉徴収 |
5,654 |
$36.82 |
$208.18K |
7,346 |
| 2026-01-25 |
Kapadia Sandip |
Chief Financial Officer |
RSU 源泉徴収 |
2,553 |
$36.82 |
$94K |
2,172 |
| 2026-01-25 |
Serafin Andrew |
Chief Strategy Officer |
RSU 源泉徴収 |
1,126 |
$36.82 |
$41.46K |
1,474 |
| 2026-01-25 |
Budur Kumar |
Chief Medical Officer |
RSU 源泉徴収 |
1,372 |
$36.82 |
$50.52K |
1,290 |
| 2026-01-24 |
Dayno Jeffrey M. |
President, CEO |
RSU 源泉徴収 |
4,785 |
$36.82 |
$176.18K |
5,715 |
| 2026-01-24 |
Kapadia Sandip |
Chief Financial Officer |
RSU 源泉徴収 |
2,239 |
$36.82 |
$82.44K |
1,574 |
| 2026-01-24 |
Serafin Andrew |
Chief Strategy Officer |
RSU 源泉徴収 |
1,116 |
$36.82 |
$41.09K |
1,384 |
| 2026-01-24 |
Budur Kumar |
Chief Medical Officer |
RSU 源泉徴収 |
1,153 |
$36.82 |
$42.45K |
1,035 |
| 2026-01-22 |
Dayno Jeffrey M. |
President, CEO |
RSU 付与（制限付株式） |
52,900 |
- |
- |
52,900 |
| 2026-01-22 |
Kapadia Sandip |
Chief Financial Officer |
RSU 付与（制限付株式） |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Serafin Andrew |
Chief Strategy Officer |
RSU 付与（制限付株式） |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Budur Kumar |
Chief Medical Officer |
RSU 付与（制限付株式） |
12,200 |
- |
- |
12,200 |
| 2026-01-22 |
Zaeske Adam H. |
Chief Commercial Officer |
RSU 付与（制限付株式） |
16,200 |
- |
- |
16,200 |
| 2026-01-15 |
Kapadia Sandip |
Chief Financial Officer |
情報に基づく売り |
20,961 |
$35.92 |
$752.83K |
- |
| 2025-12-12 |
Dayno Jeffrey M. |
President, CEO |
情報に基づく売り |
5,933 |
$40.11 |
$237.96K |
- |
| 2025-12-05 |
Kapadia Sandip |
Chief Financial Officer |
情報に基づく売り |
20,000 |
$39.54 |
$790.9K |
- |
| 2025-11-21 |
Kapadia Sandip |
Chief Financial Officer |
情報に基づく売り |
3,427 |
$35.00 |
$119.95K |
- |
| 2025-09-30 |
Kapadia Sandip |
Chief Financial Officer |
RSU 源泉徴収 |
24,039 |
$27.56 |
$662.51K |
20,961 |
| 2025-08-28 |
Valor Iv Pharma Holdings, Llc |
10 Percent Owner |
その他（売り） |
6,618,033 |
- |
- |
- |
| 2025-08-15 |
Kapadia Sandip |
Chief Financial Officer |
情報に基づく売り |
21,573 |
$36.50 |
$787.38K |
- |
| 2025-05-25 |
Graf R. Mark |
Director |
RSU 付与（制限付株式） |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Gracias Antonio J. |
Director |
RSU 付与（制限付株式） |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Sender Gary |
Director |
RSU 付与（制限付株式） |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Szyper Linda M |
Director |
RSU 付与（制限付株式） |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Sabater Juan A. |
Director |
RSU 付与（制限付株式） |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Anastasiou Peter |
Director |
RSU 付与（制限付株式） |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-15 |
Philip Ron M |
Director |
RSU 付与（制限付株式） |
14,522 |
$34.23 |
$497.09K |
14,522 |
| 2025-05-01 |
Budur Kumar |
Chief Medical Officer |
RSU 源泉徴収 |
8,869 |
$29.86 |
$264.83K |
9,881 |
| 2025-04-07 |
Zaeske Adam H. |
Officer |
不明 |
- |
- |
- |
- |
| 2025-04-07 |
Zaeske Adam H. |
Chief Commercial Officer |
RSU 付与（制限付株式） |
30,000 |
- |
- |
30,000 |
| 2025-04-02 |
Philip Ron M |
Officer |
不明 |
- |
- |
- |
- |
| 2025-04-02 |
Philip Ron M |
Director |
RSU 付与（制限付株式） |
14,077 |
$32.53 |
$457.92K |
14,077 |
| 2025-04-01 |
Kapadia Sandip |
Chief Financial Officer |
情報に基づく売り |
740 |
$33.12 |
$24.51K |
- |
| 2025-03-29 |
Kapadia Sandip |
Chief Financial Officer |
RSU 源泉徴収 |
8,014 |
$33.19 |
$265.98K |
6,986 |
| 2025-03-03 |
Dierks Jeffrey |
Chief Commercial Officer |
オプション行使（売却） |
4,869 |
$8.22 |
$40.02K |
- |
| 2025-01-27 |
Kapadia Sandip |
Chief Financial Officer |
情報に基づく売り |
1,775 |
$38.05 |
$67.55K |
- |
| 2025-01-27 |
Dierks Jeffrey |
Chief Commercial Officer |
情報に基づく売り |
1,629 |
$38.02 |
$61.94K |
- |
| 2025-01-25 |
Dayno Jeffrey M. |
President, CEO |
RSU 付与（制限付株式） |
52,000 |
- |
- |
52,000 |
| 2025-01-25 |
Kapadia Sandip |
Chief Financial Officer |
RSU 付与（制限付株式） |
18,900 |
- |
- |
18,900 |
| 2025-01-25 |
Dierks Jeffrey |
Chief Commercial Officer |
RSU 付与（制限付株式） |
13,450 |
- |
- |
13,450 |
| 2025-01-25 |
Serafin Andrew |
Chief Strategy Officer |
RSU 付与（制限付株式） |
10,400 |
- |
- |
10,400 |
| 2025-01-25 |
Budur Kumar |
Chief Medical Officer |
RSU 付与（制限付株式） |
10,650 |
- |
- |
10,650 |
| 2025-01-24 |
Dayno Jeffrey M. |
President, CEO |
RSU 源泉徴収 |
4,567 |
$38.01 |
$173.59K |
5,933 |
| 2025-01-24 |
Kapadia Sandip |
Chief Financial Officer |
RSU 源泉徴収 |
2,037 |
$38.01 |
$77.43K |
1,775 |
| 2025-01-24 |
Dierks Jeffrey |
Chief Commercial Officer |
情報に基づく売り |
5,125 |
$37.87 |
$194.1K |
- |
| 2025-01-24 |
Serafin Andrew |
Chief Strategy Officer |
RSU 源泉徴収 |
865 |
$38.01 |
$32.88K |
1,635 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
